The effectiveness of extracorporeal treatments is measured by the reduction of toxin levels in the blood and improvement in clinical symptoms. In some cases, serial measurements of serum toxin levels are taken to assess the ongoing need for treatment. Clinical improvement is typically observed as a reduction in symptom severity and stabilization of vital signs.
